Expand LEXX Menu
LEXX MENU

LEXX Latest Press Releases

-- April 7, 2026 --

Lexaria Applauds Eli Lilly's Foundayo(TM) Drug Approval ACCESS Newswire 9:10 AM

-- April 1, 2026 --

Lexaria to Begin New Human Clinical Study in GLP-1 ACCESS Newswire 9:20 AM

-- March 26, 2026 --

Lexaria's Robust Patent Portfolio Continues to Grow ACCESS Newswire 9:20 AM

-- March 24, 2026 --

Lexaria's Oral GLP-1 Drug Strategy Validated by Industry ACCESS Newswire 9:15 AM

-- March 4, 2026 --

Lexaria Announces New R&D Plans for 2026 ACCESS Newswire 9:25 AM

-- February 5, 2026 --

Lexaria Announces Positive Final Results From Human Pilot Study #5 ACCESS Newswire 9:15 AM

-- January 22, 2026 --

Lexaria Awarded Six Additional Patents ACCESS Newswire 9:20 AM

-- January 21, 2026 --

THE FOCUS DOCTRINE: 5 Assets Securing the 2026 Biological Choke Point Globe Newswire 9:55 AM

-- December 30, 2025 --

Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4 ACCESS Newswire 9:20 AM

-- December 23, 2025 --

Primary Endpoint Successfully Achieved in Lexaria's Phase 1b Study GLP-1-H24-4 ACCESS Newswire 9:29 AM

-- December 16, 2025 --

Lexaria Bioscience Corp. Announces Closing of $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ACCESS Newswire 4:00 PM

-- December 15, 2025 --

Lexaria Bioscience Corp. Announces $3.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules ACCESS Newswire 8:00 AM

-- November 12, 2025 --

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended ACCESS Newswire 9:10 AM
Market Data Delayed 15 Minutes